Cholesterol Balancing

Study Outline

Balancing Cholesterol – A study to determine the impact of wearing a bio-energetic chip on Total Cholesterol levels.

Study design:  A randomized trial measuring the impact of wearing a bio-energetic chip on Total Cholesterol blood levels.

                           Follow subjects for 3 months initially during the active phase.

                           Follow-up after 6 months to measure long term effectiveness.

Subjects:  Volunteers with elevated cholesterol blood levels (cholesterolemia) recruited from participating CAM practitioners.

Hypothesis:  Wearing a bio-energetic imprinted chip for 3 months will significantly lower cholesterol levels, permanently.

Variables:  Diet

Research Question:  Does wearing an EM-chip for 3 months significantly lower cholesterol.  Does this benefit last beyond 6 months.

White Paper

Title: Balancing cholesterol through wearable technology

Imagine a world without side effects and lifelong popping of expensive medications, but a smart bioenergetics solution which gives you a bracelet, imprinted with bio-information for the body on how to down regulate cholesterol, permanently.

We have observed a novel approach of contacting the body with a particular set of subtle frequencies through a wearable bracelet or chip, which can consistently lower total cholesterol levels. The timeframe of wearing the bracelet holding the bioenergetics information is between 3 – 6 months and the result is usually permanent.

A pilot study within our clinic showed a reduction of total cholesterol between 29 and 50 points in up to 7 months. And those improvements were holding 12 months later.

bio-information cholesterol study

The bio-information chip was worn directly on the body around the solar plexus region.

bio-information chip

The exact mechanism of this beneficial effect is not known, but we are speculating that the epigenetic modulation effect of the bio-information chip down regulates the expression of the HMG-reductase enzyme, resulting in lower plasma cholesterol levels.

Total cholesterol levels in the plasma are measured with standard blood tests and are inexpensive.

This study is not for people with severe hypercholesterolemia, but mild and moderate cases. And it is for people willing to work on a healthy diet and striving for a basic healthy lifestyle.


Title: Reducing and balancing elevated Total Cholesterol values by modulating HMG-CoA

Reductase through proprietary subtle energies.

Dr. Bernard Straile, BS, DC ( CAM clinician, Bioinformatics researcher)

HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol.

We have found that through introducing subtle energies in the form of specific frequencies to the body, the epigenetic expression of the targeted enzyme will change. In the case of HMG-CoA Reductase we demonstrated the downregulation of cholesterol synthesis.

This is a fundamentally new paradigm in modulating and regulating biochemical balance within the human body. We believe this is accomplished by epigenetic mechanisms changing the epigenetic expression of the HMGCR gene, downregulating HMG-CoA Reductase. This in return reduces cholesterol synthesis in the liver.

Enroll in a Study

If you are interested to participate in this study, you may send your information (name, address, telephone number, email) to the email address below to register for enrollment into the study. We will contact you shortly.

Link to email: